Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

49

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

Tags:

Previous Article

Broadly neutralizing antibodies against emerging delta-coronaviruses

Immunotherapy for glioblastoma and its microenvironment

Related Posts

Interferon-responsive intestinal BEST4/CA7+ cells are targets of bacterial diarrheal toxins

Interferon-responsive intestinal BEST4/CA7+ cells are t...

72

Post-stroke hippocampal neurogenesis is impaired by microvascular dysfunction and PI3K signaling in cerebral amyloid angiopathy

Post-stroke hippocampal neurogenesis is impaired by mic...

77

Childhood anaesthesia and autism risk: population and murine study

Childhood anaesthesia and autism risk: population and m...

62